Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | M6PR | P20645 | 2/20 | 0.44 |
| ▸ | MGAM | O43451 | 4/20 | 0.40 |
| ▸ | SI | P14410 | 4/20 | 0.40 |
| ▸ | G6PD | P11413 | 2/20 | 0.38 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.38 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1004728 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL10268031 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL13510798 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL3384820 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL2502348 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL24605082 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL2743468 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL16726423 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL12588436 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 | |
| SCHEMBL1919200 | 1.00 | M6PR (0.44) | M6PRMGAMSIG6PDFUCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3033442-B1 | METHODS FOR THE SIMULTANEOUS ELECTROLYTIC DECARBOXYLATION AND REDUCTION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORP (US) | 2019-04-03 | — | — | EP | claimed |
| EP-2971254-B1 | METHODS FOR THE ELECTROLYTIC DECARBOXYLATION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORP (US) | 2019-02-20 | — | — | EP | claimed |
| US-9957620-B2 | Methods for the simultaneous electrolytic decarboxylation and reduction of sugars | DFI USA, LLC (US) | 2018-05-01 | — | — | US | claimed |
| US-20160194765-A1 | METHODS FOR THE SIMULTANEOUS ELECTROLYTIC DECARBOXYLATION AND REDUCTION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORPORATION (US) | 2016-07-07 | — | — | US | claimed |
| EP-3033442-A1 | METHODS FOR THE SIMULTANEOUS ELECTROLYTIC DECARBOXYLATION AND REDUCTION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORP. (US) | 2016-06-22 | — | — | EP | claimed |
| US-20160024668-A1 | METHODS FOR THE ELECTROLYTIC DECARBOXYLATION OF SUGARS | DFI USA, LLC | 2016-01-28 | — | — | US | claimed |
| EP-0025467-B1 | CHROMOGENIC CHEMICAL SUBSTRATES FOR IDENTIFICATION OF MICROBIAL COLONIES | Rambach, Alain (FR) | 1983-05-11 | — | — | EP | claimed |
| WO-2021037077-A1 | PATENTIFLORIN A ANALOGS AS ANTIVIRAL AGENTS | HONG KONG BAPTIST UNIVERSITY (CN) | 2021-03-04 | — | — | WO | disclosed |
| CN-105473765-B | Make the method for sugared electrolytic decarbodylation and reduction simultaneously | DFI 美国有限责任公司 | 2019-03-29 | — | — | CN | disclosed |
| US-9957620-B2 | Methods for the simultaneous electrolytic decarboxylation and reduction of sugars | DFI USA, LLC (US) | 2018-05-01 | — | — | US | disclosed |
| US-20160194765-A1 | METHODS FOR THE SIMULTANEOUS ELECTROLYTIC DECARBOXYLATION AND REDUCTION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORPORATION (US) | 2016-07-07 | — | — | US | disclosed |
| EP-3033442-A1 | METHODS FOR THE SIMULTANEOUS ELECTROLYTIC DECARBOXYLATION AND REDUCTION OF SUGARS | DYNAMIC FOOD INGREDIENTS CORP. (US) | 2016-06-22 | — | — | EP | disclosed |
| CN-105473765-A | Methods for simultaneous electrolytic decarboxylation and reduction of sugars | DYNAMIC FOOD INGREDIENTS CORP | 2016-04-06 | — | — | CN | disclosed |
| EP-2457918-A2 | Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes | Bristol-Myers Squibb Company (US) | 2012-05-30 | — | — | EP | disclosed |